Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 (TILT-2024) by benforred | Jan 21, 2026
Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, “SIDERALE” (SIDERALE2020) by benforred | Jan 21, 2026
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes by benforred | Jan 21, 2026
Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects (LIPOKINES) by benforred | Jan 20, 2026
